For Investors

Press Releases

ReWalk Announces Extension of Share Repurchase Program

12/22/22

Reflects Confidence in Long-Term Potential of ReWalk MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Dec. 22, 2022 (GLOBE NEWSWIRE) --  ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity

Read More
Read More

Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation

11/11/22

Precedent set for all future cases as State Court verdict is legally binding and enforceable Following the outcome of this legal dispute, eligible paraplegics in Germany have an easier pathway to be provided with a ReWalk exoskeleton going forward MARLBOROUGH, Mass. and BERLIN , Nov.

Read More
Read More

ReWalk Robotics Reports Third Quarter 2022 Financial Results

11/07/22

ReWalk Has Submitted the First Case to Medicare Administrative Contractors (MACs) for Coverage and Reimbursement of the ReWalk Exoskeleton for Medicare Beneficiaries   As of November 4 th , ReWalk Has Repurchased $0.9 Million of Common Stock Since Initiation of Its Program German Federal Social

Read More
Read More

ReWalk Robotics to Report Third Quarter 2022 Financial Results on November 7, 2022

10/31/22

MARLBOROUGH, Mass.   BERLIN, Germany and YOKNEAM ILIT, Israel , Oct. 31, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2022 financial results on Monday, November 7, 2022 , at 8:30 AM Eastern

Read More
Read More

ReWalk Takes Another Step Toward Medicare Coverage

09/28/22

ReWalk to submit first cases for Medicare coverage through Medicare Administrative Contractors (MACs) Centers for Medicare and Medicaid Services (CMS) affirms that the MACs have discretion to cover and reimburse the ReWalk exoskeleton CMS also plans to further deliberate on a benefit category

Read More
Read More

German Federal Social Court Schedules Hearing on Classification of Exoskeleton Medical Devices for Spinal Cord Injured Individuals

09/12/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Sept. 12, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the German Federal Social

Read More
Read More

ReWalk Robotics Appoints Michael Lawless as Chief Financial Officer

09/08/22

Brings Significant Experience in M&A, Investor Relations, and Financial Strategy MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for

Read More
Read More

ReWalk Robotics Reports Second Quarter 2022 Financial Results

08/09/22

Highlights June 8 th Milestone Participation at Biannual CMS HCPCS   Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit Category Classification as Prosthetic for ReWalk Device          Has Submitted 510k A pplication for ReWalk Stairs and Curbs Functionality MARLBOROUGH, Mass.

Read More
Read More

ReWalk Robotics to Report Second Quarter 2022 Financial Results on August 9, 2022

08/03/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 03, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2022 financial results on Tuesday, August 9, 2022 , at 8:30 AM Eastern time .

Read More
Read More

ReWalk Robotics Announces Results of 2022 Annual Meeting

08/02/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 02, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced the results of the Company's

Read More
Read More

ReWalk Receives Court Approval for Share Repurchase Program

07/21/22

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , July 21, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that it has received Israeli

Read More
Read More

100th ReWalk Exoskeleton Supplied in Germany

06/23/22

21-year-old Lukas Gloßner from Nürnberg is the 100th paraplegic in Germany to be provided with a ReWalk Personal Exoskeleton BERLIN , June 23, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd (Nasdaq: RWLK) ("ReWalk" or "the Company"), a leading manufacturer of robotic medical technology for people

Read More
Read More
Displaying 61 - 72 of 299